Oramed Pharmaceuticals logo

Oramed Pharmaceuticals Share Price Today

(NASDAQ: ORMP)

Oramed Pharmaceuticals share price is $2.3 & ₹200.03 as on 6 Mar 2025, 2.30 'hrs' IST

$2.3

0.16

(7.48%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Oramed Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Oramed Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Oramed Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Oramed Pharmaceuticals share price movements

  • Today's Low: $2.18
    Today's High: $2.34

    Day's Volatility :6.84%

  • 52 Weeks Low: $1.99
    52 Weeks High: $3.29

    52 Weeks Volatility :39.43%

Oramed Pharmaceuticals (ORMP) Returns

PeriodOramed Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-14.74%
2.1%
0.0%
6 Months
-7.36%
-4.1%
0.0%
1 Year
-25.44%
2.2%
0.0%
3 Years
-75.06%
11.8%
-11.6%

Oramed Pharmaceuticals (ORMP) Key Statistics

in dollars & INR

Previous Close
$2.14
Open
$2.15
Today's High
$2.34
Today's Low
$2.18
Market Capitalization
$94.6M
Today's Volume
$36.0K
52 Week High
$3.29
52 Week Low
$1.9929
Revenue TTM
$0.0
EBITDA
$-12.8M
Earnings Per Share (EPS)
$0.51
PE Ratio
4.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
2.89%

How to invest in Oramed Pharmaceuticals Stock (ORMP) from India?

It is very easy for Indian residents to invest directly in Oramed Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Oramed Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Oramed Pharmaceuticals or ORMP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Oramed Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Oramed Pharmaceuticals shares which would translate to 0.378 fractional shares of Oramed Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Oramed Pharmaceuticals, in just a few clicks!

Returns in Oramed Pharmaceuticals (ORMP) for Indian investors in Rupees

The Oramed Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Oramed Pharmaceuticals investment value today

Current value as on today

₹85,102

Returns

₹14,898

(-14.9%)

Returns from Oramed Pharmaceuticals Stock

₹19,861 (-19.86%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Oramed Pharmaceuticals (ORMP)

29%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Oramed Pharmaceuticals Stock from India on INDmoney has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Oramed Pharmaceuticals

  • BML Capital Management LLC

    6.56%

  • Murchinson Ltd.

    4.34%

  • BOOTHBAY FUND MANAGEMENT, LLC

    2.10%

  • Rathbone Brothers PLC

    0.72%

  • Two Sigma Advisers, LLC

    0.60%

  • Peapod Lane Capital LLC

    0.56%

Analyst Recommendation on Oramed Pharmaceuticals

Hold

    0%Buy

    57%Hold

    42%Sell

Based on 7 Wall street analysts offering stock ratings for Oramed Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
4
4
4
Sell
3
3
3

Analyst Forecast on Oramed Pharmaceuticals Stock (ORMP)

What analysts predicted

Upside of 41.3%

Target:

$3.25

Current:

$2.30

Insights on Oramed Pharmaceuticals Stock (Ticker Symbol: ORMP)

  • Price Movement

    In the last 7 days, ORMP stock has moved up by 1.4%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 666.0K → 674.0K (in $), with an average increase of 0.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 9.21M → -19.61M (in $), with an average decrease of 313.0% per quarter
  • ORMP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 96.7%
  • ORMP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 123.7%

Oramed Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Oramed Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Oramed Pharmaceuticals (ORMP) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Oramed Pharmaceuticals Inc logo
-0.93%
-7.36%
-25.44%
-75.06%
-81.66%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Oramed Pharmaceuticals Inc logo
4.55
4.55
0.0
0.24
0.03
-0.04
NA
3.89
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Oramed Pharmaceuticals Inc logo
Hold
$94.6M
-81.66%
4.55
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Oramed Pharmaceuticals

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides. The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes. It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.
Organization
Oramed Pharmaceuticals
Employees
0
CEO
Mr. Nadav Kidron Esq.
Industry
Health Technology

Management People of Oramed Pharmaceuticals

NameTitle
Mr. Nadav Kidron Esq.
President, CEO & Executive Chairman
Dr. Miriam Kidron Ph.D.
Chief Scientific Officer & Director
Mr. Avraham Gabay
CFO, Treasurer & Secretary
Mr. Joshua Hexter
Chief Operating & Business Officer

Important FAQs about investing in ORMP Stock from India :

What is Oramed Pharmaceuticals share price today?

Oramed Pharmaceuticals share price today stands at $2.30, Open: $2.15 ; Previous Close: $2.14 ; High: $2.34 ; Low: $2.18 ; 52 Week High: $3.29 ; 52 Week Low: $1.99.

The stock opens at $2.15, after a previous close of $2.14. The stock reached a daily high of $2.34 and a low of $2.18, with a 52-week high of $3.29 and a 52-week low of $1.99.

Can Indians buy Oramed Pharmaceuticals shares?

Yes, Indians can invest in the Oramed Pharmaceuticals (ORMP) from India.

With INDmoney, you can buy Oramed Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Oramed Pharmaceuticals at zero transaction cost.

How can I buy Oramed Pharmaceuticals shares from India?

It is very easy to buy Oramed Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Oramed Pharmaceuticals (ORMP) be purchased?

Yes, you can buy fractional shares of Oramed Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Oramed Pharmaceuticals stocks?

To start investing in Oramed Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Oramed Pharmaceuticals Stock (ORMP)?

Today’s highest price of Oramed Pharmaceuticals (ORMP) is $2.34.

Today’s lowest price of Oramed Pharmaceuticals (ORMP) is $2.18.

What is today's market capitalisation of Oramed Pharmaceuticals?

Today's market capitalisation of Oramed Pharmaceuticals ORMP is 94.6M

What is the 52 Week High and Low Range of Oramed Pharmaceuticals Stock (ORMP)?

  • 52 Week High

    $3.29

  • 52 Week Low

    $1.99

What are the historical returns of Oramed Pharmaceuticals (ORMP)?

  • 1 Month Returns

    -0.93%

  • 3 Months Returns

    -7.36%

  • 1 Year Returns

    -25.44%

  • 5 Years Returns

    -81.66%

Who is the Chief Executive Officer (CEO) of Oramed Pharmaceuticals ?

Mr. Nadav Kidron Esq. is the current Chief Executive Officer (CEO) of Oramed Pharmaceuticals.